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Abstract
Background: The catabolite control protein CcpA is a transcriptional regulator conserved in
many Gram-positives, controlling the efficiency of glucose metabolism. Here we studied the role
of Bacillus cereus ATCC 14579 CcpA in regulation of metabolic pathways and expression of
enterotoxin genes by comparative transcriptome analysis of the wild-type and a ccpA-deletion
strain.
Results: Comparative analysis revealed the growth performance and glucose consumption rates
to be lower in the B. cereus ATCC 14579 ccpA deletion strain than in the wild-type. In exponentially
grown cells, the expression of glycolytic genes, including a non-phosphorylating glyceraldehyde-3-
phosphate dehydrogenase that mediates conversion of D-glyceraldehyde 3-phosphate to 3-
phospho-D-glycerate in one single step, was down-regulated and expression of gluconeogenic
genes and genes encoding the citric acid cycle was up-regulated in the B. cereus ccpA deletion strain.
Furthermore, putative CRE-sites, that act as binding sites for CcpA, were identified to be present
for these genes. These results indicate CcpA to be involved in the regulation of glucose metabolism,
thereby optimizing the efficiency of glucose catabolism. Other genes of which the expression was
affected by ccpA deletion and for which putative CRE-sites could be identified, included genes with
an annotated function in the catabolism of ribose, histidine and possibly fucose/arabinose and
aspartate. Notably, expression of the operons encoding non-hemolytic enterotoxin (Nhe) and
hemolytic enterotoxin (Hbl) was affected by ccpA deletion, and putative CRE-sites were identified,
which suggests catabolite repression of the enterotoxin operons to be CcpA-dependent.
Conclusion:  The catabolite control protein CcpA in B. cereus ATCC 14579 is involved in
optimizing the catabolism of glucose with concomitant repression of gluconeogenesis and
alternative metabolic pathways. Furthermore, the results point to metabolic control of enterotoxin
gene expression and suggest that CcpA-mediated glucose sensing provides an additional mode of
control in moderating the expression of the nhe and hbl operons in B. cereus ATCC 14579.
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Background
Bacillus cereus is an important Gram-positive, spore-form-
ing food-borne pathogen. Many strains cause either an
emetic or a diarrhoeal type of disease. The production of
emetic toxin in foods, also referred to as cereulide, may
cause nausea and vomiting. The diarrhoeal type of disease
is associated with the production of enterotoxins in the
intestines and may involve Nhe, Hbl and CytK [1-3].
Food-borne disease caused by B. cereus is generally charac-
terized by mild symptoms. However, recently more severe
cases with a lethal outcome have been described [4,5]. B.
cereus can also be the causative agent of other diseases,
such as periodontitis, fulminant endophthalmitis, and
meningitis in immuno-compromised patients [1,6-8]. B.
cereus is ubiquitously found in the environment, includ-
ing in soil. Therefore, the transfer to food is not surprising
and causes many problems [1]. In nutrient-rich environ-
ments, such as food, B. cereus shows low generation times
putatively gaining advantage from its capacity to use vari-
ous carbohydrates and proteinaceous substrates [9]. The
regulation of gene expression plays an important role in
the efficient selection of the preferred carbon and energy
source for growth. Annotation of the genome of B. cereus
ATCC 14579 predicted the regulation of gene expression
to be highly complex involving over two hundred tran-
scriptional regulators managing its 5370 open reading
frames (ORFs) [9,10]. One of these putative regulators is
the catabolite control protein CcpA, which is a member of
the LacI-family of transcriptional regulators. CcpA and the
regulatory mechanism of the catabolite repression are
highly conserved in low-GC Gram-positives [11]. B. cereus
ATCC 14579 CcpA shows 77% identity with B. subtilis
CcpA. Furthermore, CcpA in B. subtilis has been shown to
have a role in optimizing glucose metabolism and the
underlying regulatory mechanisms have recently been
reviewed [12-14]. Regulation of gene expression by CcpA
is mediated by its binding to DNA at a specific cis-binding
sequence, the Catabolite Responsive Element (CRE) [14-
16].
In recent years the regulon of B. subtilis CcpA has been
studied extensively by transcriptome analyses, revealing
genes and operons under direct and indirect control of
CcpA [17-20]. Furthermore, Moreno et al. [21] showed a
clear correlation between the glucose-repressed genes and
the presence of predicted CRE-sites. Moreover, they
showed CcpA-mediated glucose-independent regulation
of expression [21]. Other organisms for which the role of
CcpA in carbon metabolism was established are Lactoba-
cillus acidophilus [22] and Lactococcus lactis [23]. Recently,
a role for CcpA in the control of virulence of Staphylococcus
aureus [24], Streptococcus pneumoniae [25], and Clostridium
perfringens was reported [26] and reviewed [27].
Notably, comparative genomics of the different species of
the B. cereus group revealed reduced capacity to metabo-
lize carbohydrates and increased potential for protein
metabolism as compared to B. subtilis [28,29]. Here we
report on the role of CcpA in regulation of metabolism
and virulence in B. cereus ATCC 14579.
Results and Discussion
Growth and glucose utilization of the ccpA deletion strain 
compared to the wild-type
Growth of the wild-type and the ccpA deletion strain was
assessed under aerobic conditions in BHI containing 2 g/
L D-glucose, and revealed specific growth rates (μ) of
0.024 and 0.022 (h-1), respectively (Fig. 1). Statistical
analysis showed the growth rates of the wild-type and
deletion strain to be significantly different. Assessment of
glucose concentrations at different time points during
growth revealed a reduction in the glucose consumption
rate for the ccpA deletion strain compared to that of the
wild-type (Fig. 1). The glucose concentration at early-
exponential growth for both the wild-type and the ccpA
deletion strain was around 1.2 g/L, and glucose was still
available in the mid-exponential growth phase. Notably,
glucose was depleted in the wild-type culture upon entry
into the transition phase, whereas glucose depletion in
the ccpA deletion strain culture was only observed in the
stationary phase of growth.
Growth and glucose consumption Figure 1
Growth and glucose consumption. Growth (closed sym-
bols) and glucose consumption (open symbols) of the wild-
type (black) and the ccpA deletion strain (grey) in BHI. 
Arrows in indicate sampling points at OD600 of 0.2 (early-
exponential), 0.8 (mid-exponential), 4.0 (transition) and 8.0 
(stationary), for both glucose determination and transcrip-
tional analysis. Experiments shown are representative for all 
performed experiments.
0.01
0.1
1
10
0 100 200 300 400 500
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
time (min)
O
D
6
0
0BMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
Page 3 of 12
(page number not for citation purposes)
Overview of the transcriptome data
Analyses of the transcriptome data of the ccpA deletion
strain compared to the wild-type in samples taken at the
four time points indicated in figure 1, showed expression
of a large number of ORFs to be affected upon ccpA dele-
tion. Remarkably, the number of genes differentially
expressed increased from 147 at early exponential phase
to over 700 genes in the stationary phase (Fig. 2). The
large differences in gene expression in transition and sta-
tionary phase cells of the ccpA deletion strain compared to
that of the wild-type are conceivably affected by the
respective presence and absence of glucose. Furthermore,
these differences may point to the initiation of secondary
effects of the ccpA deletion in these growth phases on gene
expression and consequently cellular performance. There-
fore, transcriptome analysis was focused on the early- and
mid-exponential phase samples where glucose is still
present at high levels in the cultures of both the ccpA dele-
tion strain and the wild-type. In early-exponential phase,
103 genes showed higher expression and 44 genes
showed a lower expression in the ccpA  deletion strain
compared to the wild-type. For mid-exponential phase
cells these numbers were 127 and 54, respectively. When
corrected for overlap between regulated genes in the early-
and mid-exponential phase, a total of 173 genes expres-
sion in the exponential phase was shown to be higher in
the ccpA deletion strain compared to the wild-type and for
80 genes expression in the ccpA  deletion strain was
observed to be lower than in the wild-type (Fig. 2). Con-
sequently, genes that show a higher expression in the ccpA
deletion strain are possibly repressed by CcpA, whereas
genes that show a lower expression in the ccpA deletion
strain may be activated by CcpA in the wild-type. The
number of genes putatively regulated are similar to those
described for CcpA-regulated genes in B. subtilis [17-
19,21].
Expression ratios of six randomly chosen genes with sig-
nificantly altered expression in the ccpA deletion strain
(cggR, acoR, gapB, ymfC, fruR and odhA) were quantified
using qPCR. Expression ratios obtained by microarray
analysis were compared to ratios obtained by qPCR. The
tested genes showed the same trend in expression, with
differential expression only slightly more pronounced in
qPCR experiments, a feature observed before in such com-
parisons [30]. This indicates the microarray platform to be
suited for gene expression analysis (for qPCR data see
Additional file 1).
Identification of the B. cereus CRE-site consensus and in 
silico analysis
Direct regulation exerted by CcpA is indicated by the pres-
ence of a CRE-site. By a series of subsequent alignments
searches, the B. cereus ATCC 14579 consensus CRE-site
was identified and visualized in Figure 3 (for details see
Methods). This showed the consensus sequence to consist
of only 16-bp for B. cereus ATCC 14579, WWGWAARCG-
WWWWCAW, whereas an 18-bp consensus sequence was
reported for B. subtilis, WWTGNAARCGNWWWCAWW,
[15]. Nevertheless, a high similarity between these con-
sensus sequences exists. The B. cereus ATCC 14579
genome was scanned with the obtained CRE-site consen-
sus (Fig. 3), identifying the putative CRE-sites (see Addi-
tional file 2). A number of 76 putative CRE-sites were
identified for 83 out of 173 genes that show a higher
expression in the ccpA deletion strain compared to the
Visualization of the B. cereus ATCC 14579 CRE-site consen- sus Figure 3
Visualization of the B. cereus ATCC 14579 CRE-site 
consensus. The consensus sequence was obtained by align-
ing putative CRE-sites identified on the genome of B. cereus 
ATCC 14579 in or in front of differently expressed genes 
between the ccpA deletion strain and the wild-type.
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Differential gene expression during growth Figure 2
Differential gene expression during growth. The 
number of genes differently expressed in the ccpA deletion 
strain compared to the wild-type in four different growth 
phases (OD600 0.2 = early-exponential, OD600 0.8 = mid-
exponential, OD600 4 = transition, OD600 8 = stationary). 
Both, the genes with a higher (grey bars) and a lower (black 
bars) expression in the ccpA deletion strain are shown. The 
light grey bars indicate the number of genes putatively regu-
lated by a CRE-site, these are not shown for the transition 
and stationary phase.
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wild-type in exponential phase cells, and these 83 genes
are part of 49 putative operons [9,31]. Furthermore, 21
putative CRE-sites were identified in the promoter region
of 18 out of 80 genes with a lower expression in the ccpA
deletion strain (see Additional file 2) in exponential phase
cells, these 18 genes are part of 17 putative operons [9,31].
These results are in agreement with the general observa-
tion that activation by CcpA occurs less frequently than
repression by CcpA [21]. For B. subtilis not all identified
putative CRE-sites could be shown to be functional [15]
and the predicted CRE-sites in B. cereus should therefore
be regarded putative.
Analysis of genes differentially expressed in the ccpA 
deletion strain
The COG annotation reveals that the differentially
expressed genes are mainly involved in metabolic proc-
esses (Fig. 4), including glycolytic and gluconeogenic
genes and genes encoding the citric acid cycle (Table 1).
For approximately 35 differentially expressed genes a
homologous gene was identified to be CcpA regulated in
B. subtilis [32]. Of these genes a total number of 17 genes
were annotated to have a function in the glucose metabo-
lism (Table 1). Genes that were first identified in this
study to be putatively regulated by CcpA with an apparent
and interesting function are discussed below.
One of the glycolytic genes found to be expressed lower in
the ccpA deletion strain was yfmT. This gene encodes a
non-phosphorylating glyceraldehyde-3-phosphate dehy-
drogenase (GAPN), for which 2 putative CRE-sites could
be identified. We propose to rename yfmT as gapN, since
this gene shows similarity with gapN of the other mem-
bers of the B. cereus group, and with gapN of B. halodurans,
Streptococci and Clostridia [33]. Notably, the gene is lack-
ing in B. subtilis [29,33]. Next to the non-phosphorylating
glyceraldehyde-3-phosphate dehydrogenase, two phos-
phorylating glyceraldehyde-3-phosphate dehydrogenases
encoding genes (gapA  and gapB) are present on the B.
cereus ATCC 14579 genome. The function of GAPN in
microbial metabolism is yet unclear. Recently, Asanuma
and Hino (2006) showed a role for CcpA in expression
control of gapN in Streptococcus bovis and proposed that
NADPH is provided by GAPN activity for NADPH-
dependent biosynthetic reactions, thereby maintaining an
optimal redox balance at the same time. However, in
hyperthermophilic archaea GAPN has been shown to play
a role in accelerating glycolysis as it can produce 3-phos-
pho-D-glycerate from D-glyceraldehyde 3-phosphate in a
one-step reaction, instead of two steps[34]. As a putative
drawback, ATP is not produced in this one-step reaction.
The exact role of GAPN in B. cereus metabolism remains
to be elucidated.
The gluconeogenic genes expressed higher in the ccpA
deletion strain included ywjI and gapB. The ywjI gene is
part of the putative murA2-ywjI operon and is annotated
as a fructose-1,6-bisphosphatase. The ywjI gene of B. subti-
lis, that shows similarity to ywjI of B. cereus, is annotated
to be a fructose-1,6-bisphosphatase, as a member of the
glpX-family. The other annotated fructose-1,6-bisphos-
phatase gene for B. subtilis, fbp, which is no member of the
glpX-family, is not regulated by CcpA and deletion of this
gene seems to have no effect on gluconeogenesis [35]. A
corresponding fbp homologue appears to be absent in B.
cereus. However, on the B. cereus genome two members of
the  glpX-family of fructose-1,6-bisphosphatases are
present, of which ywjI expression was found to be affected
by  ccpA  deletion, accordingly a putative CRE-site was
identified in the promoter region of its operon. The gapB
gene encodes a NAD(P)-dependent glyceraldehyde-3-
phosphate dehydrogenase. Three putative CRE-sites were
identified for gapB in B. cereus (Table 1). In contrast, no
CRE-sites were identified for gapB in B. subtilis, and its
expression was shown to be only indirectly affected by
ccpA  deletion [36]. Furthermore, gluconeogenesis in B.
subtilis was shown to be regulated by the transcriptional
regulator CcpN [37,38]. CcpN is also present on the
genome of B. cereus ATCC 14579 and putative CcpN bind-
ing sites can be found in front of the gluconeogenic genes
encoding GapB and PckA [37]. Combined with our results
this would point to dual control of the expression of glu-
coneogenic genes in B. cereus by CcpN and CcpA.
The expression of genes with functions in routing metab-
olism towards the citric acid cycle appeared to be higher
in the ccpA deletion strain compared to the wild-type and
included ~30 genes involved in amino acid catabolism.
This included the bkd-operon (BC4163 to BC4157) that is
common among the Bacilli, and that is involved in the
catabolism of Valine and Leucine [39]. One putative CRE-
site in front of the bkd-operon and two within the operon
were identified in B. cereus ATCC 14579. Notably, CcpA
was previously shown to play no role in the regulation of
expression of this operon in B. subtilis [40]. In contrast, the
ilv-leu-operon of B. subtilis coding for biosynthesis of
branched chain amino acids has been shown to be acti-
vated by CcpA [41], whereas no involvement of CcpA was
found in regulation of expression of this operon in B.
cereus under the conditions tested. The fact that no regula-
tion of the ilv-leu-operon was observed, although its
expression on the microarray was apparent (data not
shown), could be due to a complex regulation of this
operon under the tested circumstances involving CodY
and TnrA [41,42]. Expression of several genes encoding
enzymes involved in catabolism of nucleosides was
higher in the B. cereus ccpA deletion strain, this included
the putative yuf-operon (BC3791 to BC3788) encoding
nucleoside transport under the apparent control of the BMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
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Table 1: Genes involved in B. cereus ATCC14579 glucose metabolism and their putative CRE-sites
Gene Operon¶ Annotation BC nr. RZC nr. ΔccpA/WT † CRE‡
early mid
Glycolysis
ptsG# 1 PTS system, glucose-specific IIABC component BC4050 RZC06596 0.52 1.12 2
ptsH# 2 Phosphocarrier protein HPr BC4049 RZC00081 0.56 1.10 +
ptsI# 3 Phosphoenolpyruvate-protein phosphotransferase BC4048 RZC06595 0.66 1.16 1
pgi Glucose-6-phosphate isomerase BC4898 RZC03793 0.31 0.20 1
pfkA 1 6-phosphofructokinase BC4600 RZC02283 0.45 0.47 -
pykA 2 Pyruvate kinase BC4599 RZC01414 0.29 0.33 -
fbaA Fructose-bisphosphate aldolase BC5335 RZC03557 0.39 0.52 2
cggR# 1 Central glycolytic genes regulator BC5141 RZC08032 0.49 0.73 -
gapA# 2 Glyceraldehyde-3-phosphate dehydrogenase BC5140 RZC00210 0.36 0.59 -
pgk* # 3 Phosphoglycerate kinase BC5139 RZC00211 0.49 0.41 -
pgk* # 3 Phosphoglycerate kinase BC5138 RZC08031 0.53 0.46 -
tpiA# 4 Triose-phosphate isomerase BC5137 RZC08030 0.62 0.51 -
pgmA# 5 Phosphoglycerate mutase BC5136 RZC05843 0.48 0.38 -
eno# 6 Phosphopyruvate hydratase BC5135 RZC02971 0.42 0.51 -
gapN NADP-dependent glyceraldehyde-3-P dehydrogenase BC0868 RZC03841 0.31 0.26 2
Pyruvate dehydrogenase
pdhA# 1 Pyruvate dehydrogenase (acetyl-transferring) BC3973 RZC01920 1.24 0.77 2
pdhB# 2 Pyruvate dehydrogenase (acetyl-transferring) BC3972 RZC01921 1.47 0.79 +
pdhC# 3 Dihydrolipoyllysine-residue acetyltransferase BC3971 RZC06754 1.52 0.95 +
pdhD# 4 Dihydrolipoyl dehydrogenase BC3970 RZC07919 1.28 1.01 +
Overflow metabolism
alsS§ 1 Acetolactate synthase large subunit BC0883 RZC01898 1.04 0.54 2
alsD§ 2 Alpha-acetolactate decarboxylase BC0884 RZC01896 0.92 0.58 +
Ldh L-lactate dehydrogenase BC1924 RZC05932 0.44 1.05 -
lctP L-lactate permease BC0612 RZC01585 0.34 1.21 -
pta§ Phosphate acetyltransferase BC5387 RZC05214 0.61 0.70 1
ackA§ Acetate kinase BC4637 RZC02436 0.93 1.29 1
Citric acid cycle
citZ§ 1 Citrate synthase BC4594 RZC01265 3.76 2.23 1
citC§ 2 Isocitrate dehydrogenase [NADP] BC4593 RZC01263 5.56 4.38 1
mdh§ 3 Malate dehydrogenase BC4592 RZC01264 5.81 4.32 +
citB§ Aconitate hydratase BC3616 RZC04993 1.62 1.26 1
odhA§ 1 Oxoglutarate dehydrogenase BC1252 RZC06639 2.07 3.80 4
odhB§ 2 Dihydrolipoyllysine-residue succinyltransferase BC1251 RZC03695 2.36 3.97 +
sucC§ 1 Succinate-CoA ligase (ADP-forming) BC3834 RZC02282 8.23 6.32 1
sucD§ 2 Succinate-CoA ligase (ADP-forming) BC3833 RZC02281 7.74 7.57 +
sdhC§ 1 Succinate dehydrogenase BC4518 RZC05750 4.02 4.02 1
sdhA§ 2 Succinate dehydrogenase BC4517 RZC07054 3.70 3.70 1
sdhB§ 3 Succinate dehydrogenase BC4516 RZC07053 3.76 5.64 +
citG§ Fumarate hydratase BC1712 RZC03022 1.29 1.49 2
Gluconeogenensis
fbpA Fructose-bisphosphatase BC4962 RZC03080 0.75 0.74 2
gapB Glyceraldehyde-3-P dehydrogenase BC4583 RZC07229 1.74 2.79 3
pckA Phosphoenolpyruvate carboxykinase (ATP) BC4762 RZC07251 1.37 1.09 1
ywjI Fructose-bisphosphatase BC5333 RZC00125 3.73 3.34 +
§ Genes of which expression of their homologous gene in B. subtilis was CcpA dependent [18,19,21].
# Genes of which effects of ccpA deletion on expression were shown to be indirect in B. subtilis [18, 19, 21].
* pgk is represented on the microarray by two different amplicons, as Pgk is annotated in the ERGO database to be encoded by two genes.
¶ Numbers indicate the order of genes within one operon.
† Ratios are presented as expression in the ccpA deletion strain compared to the wild-type (WT), expression in the wild type is set to 1. Early- and mid-exponential phase data 
are shown.
‡ In this column it is indicated whether a putative CRE-site was identified for the gene. Numbers indicate the number of putative CRE-sites identified, a + indicates that a gene 
is in the same operon as a gene for which a putative CRE-site was identified, and a - indicates no putative CRE-site could be identified.BMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
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transcriptional regulator encoded by the also higher
expressed ymfC (BC3792), for both the regulator and the
yuf-operon putative CRE-sites could be identified (see
Additional file 2). Interestingly, expression of two puta-
tive operons with an apparent function in catabolism was
higher in the ccpA deletion strain, and possible functions
were assessed using in silico analysis. The first operon
(BC0378-BC0380), which is not present in B. subtilis, con-
sists of three genes and based on phylogenetic studies of
the protein sequences it is suggested to annotate the genes
as an L-fuculose phosphate aldolase [43] (BC0378), an L-
fucose and/or arabinose isomerase (BC0379) and an L-
fuculose phosphate aldolase (BC0380). This suggest a
function for this operon in the catabolism of fucose and/
or arabinose. Consequently, names and functions that we
suggest are fclI for the L-fucose isomerase (BC0379), fclK
for the L-fuculokinase (BC0378) and fclA for the L-fucu-
lose phosphate aldolase (BC0380) (Fig. 5). A putative
CRE-site could be identified in front of this operon. The
second operon consists of three genes and in silico analysis
of this operon (BC1739-1741) suggested the transporter
protein (BC1739) to function as a proton/sodium-aspar-
tate symporter [44], as an alternative to gltT. Subse-
quently, aspartate can be converted into ammonia and
fumarate by the aspartate ammonia lyase (BC1740), after
which fumarate can be metabolized to malate by one of
the two fumarate hydratases encoded on the genome of B.
cereus. The gene BC1741 encodes a malic enzyme, MalS,
which is responsible for converting malate into pyruvate.
This suggests that the operon encodes enzymes involved
in the catabolism of aspartate to pyruvate. This operon is
unique for the species of the B. cereus group, as the genes
are not found as an operon in genomes of other bacteria.
A putative CRE-site was identified for the first gene of the
operon (Fig. 5). The two-component system (BC1742-
BC1743) next to this operon shows high similarity with
the two-component system GlnK-GlnL of B. subtilis,
which is involved in glutamine utilization [45]. Whether
BC1742-BC1743 functions as a two-component system,
involved in aspartate sensing and triggering expression of
enzymes involved in its metabolism, remains to be eluci-
dated.
Glutamate is a product of protein and amino acid catabo-
lism and acts as link between nitrogen and carbon metab-
olism, mediated by glutamate synthase and glutamate
dehydrogenase, as described for B. subtilis [46,47]. The B.
subtilis genome contains a glutamate synthase (gltAB) and
two glutamate dehydrogenases (rocG and gudB) of which
the GudB dehydrogenase appears to be inactive [47].
Glutamate biosynthesis in B. subtilis has recently been
shown to be tightly regulated by interaction of RocG and
GltC [48], but these genes are not encoded on the B. cereus
genome. The microbial glutamate synthases generally
belong to the NADPH-GltS family of glutamate synthases
and are encoded by two genes [49]. In the glutamate syn-
thase reaction L-glutamate is produced from L-glutamine
and 2-oxoglutarate, with the latter compound derived
from the citric acid cycle [49]. The gltAB operon of B. sub-
tilis is suggested to be regulated by CcpA [46,50]. On the
Functional classes of differentially expressed genes Figure 4
Functional classes of differentially expressed genes. Functional classes according to COG to which the differently 
expressed genes in the ccpA deletion strain compared to the wild-type belong, for both the early-exponential (0.2) and mid-
exponential (0.8) growth phase. Both, genes with a higher (black) and a lower (grey) expression in the ccpA deletion strain are 
shown. COG categories indicated are J: Translation, K: Transcription, L: Replication, recombination and repair, D: Cell cycle 
control, mitosis and meiosis, V: Defense mechanisms, T: Signal transduction mechanism, M: Cell wall/membrane biogenesis, N: 
Cell motility, U, Intracellular trafficking and secretion, C: Energy production and conversion, G: Carbohydrate TM, E: Amino 
acid TM, F: Nucleotide TM, H: Coenzyme TM, I: Lipid TM, P: Inorganic ion TM, Q: Secondary metabolites TM, R: General func-
tion prediction only, S: Function unknown. TM: Transport and metabolism.
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genome of B. cereus ATCC 14579 only one glutamate syn-
thase gene (gltA) is present and its expression at various
phases of growth is similar in the wild-type and its ccpA
deletion strain, indicating that its expression is not regu-
lated by CcpA. Moreover, it is unclear to which family of
glutamate synthases GltA of B. cereus belongs. Interest-
ingly, gudB was the only gene present on the genome of B.
cereus  encoding a glutamate dehydrogenase, and its
expression was observed to be clearly higher in the ccpA
deletion strain (Table 1). Glutamate dehydrogenase is
responsible for the reaction from L-glutamate to 2-oxogl-
utarate linking L-glutamate to the citric acid cycle [51].
Higher expression of gudB in the ccpA deletion strain com-
pared to the wild-type, together with the fact that it is the
only glutamate dehydrogenase annotated on the genome
of B. cereus suggests that GudB is the active glutamate
dehydrogenase for B. cereus. This is supported by the fact
that the 9-bp sequence, encoding the 3 amino acids caus-
ing the inactivity of GudB in B. subtilis [47], are absent in
the gudB sequence of B. cereus ATCC 14579. Two putative
CRE-sites in front of and one within gudB were identified
pointing to CcpA-controlled expression in B. cereus.
B. subtilis contains a large number of carbohydrate cata-
bolic pathways [29], whereas the number of these path-
ways is limited in B. cereus. The observed deficiency of the
B. subtilis ccpA deletion strain in growth with ammonium
as the sole nitrogen-source, has been attributed to the reg-
ulation of the gltAB genes by CcpA [46,50] and the read-
through transcription of the rocG gene [47]. The lack of
regulation of gltA in B. cereus by CcpA, together with a
similarity to the B. subtilis gltA of only 46%, offers an
explanation for the observation that the ccpA  deletion
strain of B. cereus is able to grow with ammonium as the
sole nitrogen source (data not shown), conceivably with
GudB as the active glutamate dehydrogenase.
The role of CcpA in optimisation of glucose metabolism
is apparent, since glycolytic enzymes were expressed lower
and expression of genes encoding citric acid cycle
enzymes was shown to be higher in the ccpA  deletion
strain compared to the wild-type. Up-regulation in the
ccpA deletion strain was found for ~30 genes encoding
enzymes involved in protein, peptide and amino acid
metabolism (see Additional file 1). This is seemingly in
contrast with the proposed preferred use of proteinaceous
Putative CcpA-controlled metabolic pathways in B. cereus Figure 5
Putative CcpA-controlled metabolic pathways in B. cereus. Two operons observed to be higher expressed in the ccpA 
deletion strain compared to the wild-type with their proposed functions and between brackets the expression in the ccpA 
deletion strain compared to the wild-type in the early- and mid-exponential growth phase, respectively. Putative CRE-sites are 
indicated in front of the operon, the open arrow in the flow scheme stands for transport into the cell, whereas the closed 
arrows stand for reactions. L-Asp stands for L-Aspartate and P stands for phosphate.
L-Fucose
L-Fuculose
L-Fuculose-1-P
Lactaldehyde Glycerone-P
FclI (4.0 / 4.4)
FclK (6.6 / 9.4)
FclA (3.4 / 4.4)
BC0378 BC0380 BC0379
AGAAAACGCTTACA
L-Asp out
in
Fumarate
NH
3
Malate
H2O
Pyruvate
NAD+
NADH + CO2
BC1739 (6.5 / 5.1)
BC1740 (NA / NA)
BC1741 (4.6 / 4.3)
Fumarate hydratase
BC1739 BC1741 BC1740
TGAAAGCGTTCGCA
BC0379
BC0380
BC0378
L-AspBMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
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substrates for growth of B. cereus, a hypothesis put forward
by Ivanova et al. [9]. This hypothesis was supported by the
annotation of a large number of genes encoding proteo-
lytic enzymes, a multiplicity of peptide and amino acid
transporters, and a large variety of amino acid degradation
pathways. However, under the conditions tested glucose
is used as the carbon and energy source (Fig. 1) and genes
encoding enzymes involved in protein, peptide and
amino acid catabolism appear to be subject to catabolite
repression, indicating that under the conditions tested,
glycolysis rather than protein catabolism is the preferred
energy generation route of B. cereus ATCC 14579.
CcpA-mediated catabolite control of enterotoxin gene 
expression in B. cereus
In early- and mid-exponential phase cells the expression
of the nhe-operon (BC1809-BC1811), coding for the non-
hemolytic toxin Nhe [52], was shown to be higher in the
ccpA  deletion strain compared to the wild-type. This
higher expression was even more apparent in the station-
ary phase where an almost 20-fold stimulation was
observed (Fig. 6). Furthermore, a putative CRE-site was
identified for this operon. For the hbl-operon (BC3104-
BC3102), coding for the HBL enterotoxin [53], an 8-fold
increase in the ccpA deletion strain was seen in the station-
ary phase and a putative CRE-site could be identified (Fig.
6). Differential expression of cytK, encoding the entero-
toxin Cytotoxin K [4], was not observed under the condi-
tions tested, and no putative CRE-site could be identified.
These results indicate involvement of CcpA in the catabo-
lite control of the expression of at least two major entero-
toxins in B. cereus ATCC 14579. Many bacteria use glucose
as their preferred carbon and energy source as it can be
obtained from plant-derived polysaccharides, which can
be found in many environments including foods. We
hypothesize that glucose can function as a signalling mol-
ecule enabling CRE site-mediated, CcpA-dependent
repression of gene expression for microorganisms such as
Lactobacillus plantarum [54] and B. cereus that occur in sev-
eral environments, including soil, plant and the human
gastro intestinal (GI) tract. In the GI tract, in the absence
of glucose, CcpA-dependent repression is thus lifted, and
this allows for induction of pathways involved in catabo-
lism of other substrates present in the GI tract such as
fucose, a major degradation product of mucus related fuc-
osylated glycans [55]. Notably, results of this study sug-
gest the putative fucose utilisation operon of B. cereus to
be repressed by CcpA in the presence of glucose, and this
pathway may thus be activated in the GI-tract under glu-
cose limiting conditions. A similar mode of regulation
seems applicable for the nhe and hbl enterotoxin operons,
for which the combination of transcriptome data and the
identification of putative CRE-sites, suggest these to be
CcpA controlled as well. Our results offer an explanation
for the observations recently made by Ouhib et al. [56],
who showed that final enterotoxin levels reached,
depended on the carbon and energy sources used for
growth, with the lowest levels reached with cells grown on
glucose. The anaerobic growth transcriptional regulators
FNR and ResD have recently been found to play a role in
enterotoxin production also, next to PlcR [57-59], and
combined with our data, this points to an elaborate con-
trol of enterotoxin production in B. cereus at the transcrip-
tional level based on a variety of input signals mediated
by a range of transcriptional regulators. Notably, CcpA
has been reported also to play a role in toxin formation in
C. perfringens [26], and in S. aureus deletion of ccpA was
shown to affect the expression of the virulence gene hla,
encoding α-hemolysin [24].
Conclusion
B. cereus ATCC 14579 catabolite control protein CcpA is
involved in optimizing the catabolism of glucose with
concomitant repression of a range of metabolic pathways.
Furthermore, CcpA-mediated glucose sensing is shown to
provide an additional mode of control in moderating the
expression of the nhe- and hbl-operon in this human path-
ogen.
Methods
Bacterial strains, culture media, growth conditions, and 
genetic methods
B. cereus ATCC 14579 and its ccpA deletion strain FM1403
were cultured in brain heart infusion broth (BHI, Becton
and Dickinson, The Netherlands) medium at 30°C, with
shaking at 200 rpm. The growth of the culture was moni-
tored by measurement of the optical density at OD600. D-
glucose concentrations were measured by use of a D-glu-
cose measuring kit (Boehringer). Growth experiments and
glucose measurements were performed in three fold. Plas-
mid DNAs were purified from E. coli with a Qiaprep Spin
Miniprep kit (Westburg, Leusden, The Netherlands). Pwo
polymerase (Roche Diagnostics, Almere, The Nether-
lands) was used for PCR generated fragments that were
used in cloning and Taq polymerase (Fermentas, Amers-
foort, The Netherlands) was used in control PCRs. E. coli
HB101/pRK24 [60] was used as the donor host in conju-
gation experiments. The antibiotics used were ampicillin
(Sigma, Zwijndrecht, The Netherlands) at a concentration
of 50 μg/ml, kanamycin (Sigma) at a concentration of 70
μg/ml, erythromycin (Sigma) at a concentration of 150
μg/ml (for E. coli) or 5 μg/ml (for B. cereus), spectinomy-
cin (Sigma) at a concentration of 100 μg/ml, and poly-
myxin B (VWR, Amsterdam, The Netherlands) at a
concentration of 50 μg/ml for counter-selection against E.
coli upon conjugation.
Construction of ccpA deletion strain
To construct a double cross-over deletion strain of ccpA,
an ~3.5-kb PCR product, comprising ccpA and 1-kb flank-BMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
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ing regions was obtained by use of forward primer ccpA-
KOsacIforw (TCgagctcAGATTACGTTGATGTTATTC) and
reverse primer ccpAKOxbaIrev (TGtctagaAGAAGAA-
GAAAAAGAGGAAGAAAT). This PCR product was cloned
into pGemT-easy (Promega, Leiden, The Netherlands)
according to the manufacturer's protocol resulting in
pGemTccpA. Subsequently, an erythromycin-resistance
cassette amplified from pUC18ERY [61] with forward
primer ErycasFBsrGI (TCtgtacaGTCCGCAAAA-
GAAAAACG) and reverse primer ErycasRClaI (TCatcgat-
CATACCTAATAATTTATCTAC) was cloned into
pGemTccpA after digesting both with Bsp1407I (BsrGI)
and Bsu15I (ClaI) (Fermentas). The insert of the resulting
plasmid, comprising the 1-kb flanking regions and the
erythromycin-resistance cassette was cloned into the con-
jugal vector pATΔS28 [62] by digestion of the insert and
the vector with XbaI and SacI (Fermentas). The resulting
plasmid pATΔCcpAery was isolated from DH5α and
transformed into E. coli HB101/pRK24. The resulting
strain was used in a conjugation experiment with B. cereus
ATCC 14579 following established procedures [63].
Transconjugants were obtained by selection for spectino-
mycin sensitivity and erythromycin resistance and one
was analysed in comparison with the wild-type strain.
PCR and Southern Blot analysis confirmed the deletion of
ccpA  by double homologous recombination (data not
shown). The B. cereus ccpA deletion strain was designated
B. cereus FM1403.
RNA isolation
RNA was extracted from both the ccpA deletion strain and
the wild-type at four time points in the growth curve at
OD600 of 0.2, 0.8, 4 and 8 which corresponds to early-
exponential, mid-exponential, transition and stationary
phase of growth from two independent cultures per phase
by using RNAwiz (Ambion, Huntingdon, United King-
dom) according to the manufacturers protocol. Residual
DNA from the RNA preparations was enzymatically
removed by using TURBO DNA-free (Ambion). Extracted
RNA samples were stored in 70% EtOH, 0.3 M sodium
acetate buffer (pH 5.2) at -80°C.
Microarray construction and transcriptome analysis
Amplicon based DNA-microarrays were constructed for B.
cereus  ATCC 14579 as described for L. lactis IL1403
[64,65] with modifications as detailed below. Amplicons
were designed on 5199 genes selected from the 5311
annotated genes (ORFs smaller than 80-bp were omitted)
on the genome of B. cereus ATCC 14579 [9]. To reduce
cross-hybridization between probe and target DNA
sequences the amplicons had sizes of 70 – 700-bp
(depending on gene sizes) and comprised the most
unique part of a gene. The amplicons were synthesized by
EuroGentec (Seraing, Belgium) in two amplification
steps. In the first amplification step, primers were used
with a unique tag-sequence for B. cereus ATCC 14579 (for-
ward primers were extended with the sequence: 5'-TCG-
GGCAGCTGCTCC-3'; and reverse primers with the
sequence: 5'-TGGCGCCCCTAGATG-3'). Two copies of
each amplicon were present per array, resulting in micro-
arrays comprising 10398 spots.
Normalized expression data (Feature Extract, Agilent) for
each spot was used in a statistical analysis. The biological
replicate experiments were merged with the web-sup-
ported VAMPIRE microarray suite, based on a Bayesian
frame work. Furthermore, VAMPIRE calculated p-values
for individual spots and subsequently used this p-value to
identify statistically differentially expressed spots between
compared growth conditions by use of a false discovery
rate (FDR) of 0.05 as a threshold [66,67]. In addition,
only ORFs of which both individual spots passed the FDR
based threshold were considered to be putatively differen-
tially regulated. Expression ratios per ORF were estab-
lished by calculating the average of the log-values of
individual spots. This value (R) was then used to calculate
the average expression ratio (10R) per ORF. Finally, only
ORFs that showed a change in expression of at least 2-fold
(up/down) were considered to be differentially expressed.
Microarray data are submitted to the GEO database with
accession number: GSE7843.
To determine gene similarity, homology and gene context
NCBI BLAST and the ERGO database were used [10],
Putative CcpA-regulated enterotoxin operons Figure 6
Putative CcpA-regulated enterotoxin operons. Posi-
tioning of CRE-sites and PlcR binding sites in two major 
enterotoxin operons encoding Nhe and Hbl of B. cereus 
ATCC 14579. Ratios of gene regulation are given as found in 
the ccpA deletion strain compared to the wild-type, for the 
four different growth phases, early- and mid-exponential, 
transition and stationary phase, respectively. Closed arrows 
indicate the approximate position of the identified CRE-site, 
open arrows indicate binding sites for the pleiotropic regula-
tor PlcR [59].
hblC hblA hblD
nheA nheC nheB
2.3 / 1.9 / 1.0 / 18.0 2.5 / 2.2 / 0.9 / 18.8 1.8 / 2.2 / 1.3 / 7.6
1.2 / 1.1 / 1.5 / 8.1 1.2 / 1.0 / 1.5 / 4.7 1.2 / 1.1 / 1.3 / 3.7
AGAGAACGTTCTCA CGTAAGCGCTTACA
TGCAAACGTATGCA
PlcR
PlcR
450 bp
750 bpBMC Microbiology 2008, 8:62 http://www.biomedcentral.com/1471-2180/8/62
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while KEGG [68] was used for assessment of metabolic
functions and pathways. Whether succeeding genes were
part of one operon was determined according to operon
prediction as performed by [31].
Definition and identification of B. cereus CRE-site
The 350-bp upstream and 150-bp downstream sequences
of the translation start of genes identified by the array
experiments to be significantly higher expressed in the
ccpA deletion strain compared to the wild-type strain for
early- and mid-exponential growth were analyzed with
AlignACE 3.1 [69], which searches the input sequences for
stretches of nucleotides which align between the different
input sequences. The 13-bp CRE-sites identified by Alig-
nACE were aligned with MUSCLE 3.6 [70] and a Hidden
Markov Model (HMM) was constructed with the HMMER
package [71]. The HMM was used to search CRE-sites in
the complete genome sequence of B. cereus ATCC 14579
[9], and not only the 350-bp upstream and 150-bp down-
stream sequences significantly higher expressed genes in
the ccpA deletion strain. Subsequently, to analyse whether
the  B. cereus consensus was longer than 13-bp, the
obtained sites after the HMM search were extended to 18-
bp, as has been the reported length for B. subtilis [15]. The
resulting extended CRE-sites were again aligned using
MUSCLE 3.6 [70]. This alignment was subsequently visu-
alized with WebLogo [72] and a iteration HMM search
was performed on the B. cereus ATCC 14579 sequence [9]
to identify all putative CRE-sites confirming to the new
alignment in the B. cereus ATCC 14579 genome.
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